Trump’s promise to lower drug prices rattles Swiss pharma stocks
Roche and Novartis lost up to 3% in Zurich on Monday morning.
Keystone / Georgios Kefalas
Select your language
Generated with artificial intelligence.
Listening: Trump’s promise to lower drug prices rattles Swiss pharma stocks
US President Trump wants to make medicines, some of which are exorbitantly expensive, cheaper in the US. This would mean huge losses for drugmakers, including those in Switzerland.
Shares in the pharmaceutical sector have come under heavy pressure worldwide due to concerns about profitability in the US business. US President Donald Trump wants to lower prices for prescription drugs in the USA and is therefore targeting the entire industry.
One of the “most consequential decrees” in US history will be signed on Monday, the Republican announced on his online platform Truth Social. Trump had already held out the prospect of an “earth-shattering” announcement last week. US media had already speculated that it could be about drug prices.
The fact that Trump now wants to get serious has put pharmaceutical shares under heavy pressure internationally: the losses are likely to extend to the US stock markets via Japan and Europe. In European trading on Monday, Sanofi and Novo Nordisk were hit particularly hard with losses of almost 6%. Shares in AstraZeneca and GSK fell by up to 4% in London. Roche and Novartis lost up to 3% in Zurich. Pfizer was down 2.3% in pre-market trading in New York.
More
More
US tariffs pressure Swiss pharma powerhouse
This content was published on
Looming US pharma tariffs could challenge the status quo in pharmaceutical hubs like Switzerland as investment shifts to the US.
Trump wants to force pharmaceutical companies to accept internationally comparable prices. He sees his country at a disadvantage due to high prices. In the US, there is no central government price regulation that applies to all medicines. The pharmaceutical industry plays the most important role in the question of how much a drug costs – government influence is limited. This sometimes leads to enormously high prices – in an international comparison, many drugs in the US are significantly more expensive.
The world wonders why prescription drugs are so much more expensive in the US than in other countries around the world, even though they are produced in the same laboratory by the same company, Trump wrote. He promised that drug prices in the US would fall by 30-80% “almost immediately”.
Translated from German by DeepL/jdp
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
Did you find this explanation helpful? Please fill out the short survey below to help us understand your needs.
External Content
Don’t miss your chance to make a difference! Take our survey and share your thoughts.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
Swiss government seeks better labour integration of Ukrainian refugees
This content was published on
The Swiss government has now set a goal of 50% of Ukrainian refugees to be in employment by the end of 2025, compared with 38% at present.
Blatten declares ‘special situation’ as glacier collapses
This content was published on
The government in Canton Valais has declared a “special situation” in connection with the gradual collapse of the Birch glacier above Blatten.
Swiss government greenlights Ruag sale of Leopard tanks to Germany
This content was published on
The defence company Ruag MRO is allowed to sell 71 Leopard 1 battle tanks to Germany. However, the tanks may not be sold to Ukraine.
Foie gras sold in Switzerland must declare painful production process
This content was published on
Starting July 1, the sale of foie gras in Switzerland must make reference to the painful procedures performed on the animal.
Swiss economics minister seeks progress on US tariff negotiations by July
This content was published on
Swiss Economics Minister Guy Parmelin is hoping for results in the tariff negotiations with the US by the beginning of July.
UN weather agency expects new temperature record soon
This content was published on
A new global temperature record is likely to be set in the next five years, according to the World Meteorological Organisation in Geneva.
Geneva proposed as possible site for Ukraine-Russia talks
This content was published on
US special representative for Ukraine, Keith Kellogg, has said that Geneva is being considered as a venue for talks between Russia and Ukraine.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.